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Introduction
the serotonin receptor 2C (HtR2C) is a G protein-coupled 
receptor located on the X chromosome. Binding studies 
indicate that the receptor is expressed exclusively in the 
brain, predominantly in neurons (Pompeiano et al. 1994). 
Mouse studies and the development of weight-loss drugs 
like Fen-Phen validated the serotonin receptor 2C (HtR2C) 
protein as an anti-obesity drug target (Miller 2005). In 
addition, HtR2C plays a central role in the regulation of 
mood and anxiety. It has also been implicated in depres-
sion, suicide, and schizophrenia (see Di Giovanni et al. 
2011 for reviews). the HtR2C protein receptor is targeted 
by second generation anti-psychotics used for mania and 
depression, which block the receptor activity. One major 
side effect of these substances is weight gain (Lett et al. 
2012), and there is genetic evidence that HtR2C is associ-
ated with the anti-psychotic-induced weight gain (Sicard 
et al. 2010). Direct investigation into the receptor function 
is limited, as it is expressed in neurons that are accessible 
only postmortem.
the receptor is encoded by a complex transcription unit 
spanning at least 326 kilobase pairs. Its pre-mRnA under-
goes extensive processing that includes alternative splicing 
as well as editing of exon Vb, generating a total of 25 iso-
forms. Skipping of exon Vb generates a truncated protein 
isoform. Studies in transfected cells show that the truncated 
isoform forms a heterodimer with the full-length receptor, 
causing an entrapment in the endoplasmic reticulum and 
decrease of active cell surface receptor (Martin et al. 2012). 
the full-length protein isoforms are generated through edit-
ing and SnORD115 action. Central to the regulation of the 
HtR2C editing in exon Vb, is the formation of an extended 
stem-loop structure that is the substrate for RnA editing 
through ADAR2. the formation of the non-edited form is 
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promoted by the non-coding RnA SnORD115 (MBII-52 
in mouse). SnORD115 is a C/D box snoRnA that is further 
processed into smaller RnAs (Kishore et al. 2010; Falaleeva 
and Stamm 2013). SnORD115 binds to the double-stranded 
region that is regulated in exon Vb (Kishore and Stamm 
2006b). the mouse and human orthologues of SnORD115 
are almost identical (>90 % identity) and MBII-52 works on 
both human and mouse HtR2C reporter constructs (Kishore 
and Stamm 2006a). SnORD115 is absent in patients with 
Prader–Willi syndrome, and mouse models indicate that a 
deregulation of the serotonergic system contributes to the 
disease (Morabito et al. 2010; Doe et al. 2009).
In contrast to the well-studied coding region of the 
HtR2C receptor pre-mRnA, little is known of the extended 
5′ untranslated region of the receptor pre-mRnA that con-
tains two introns and three exons (Fig. 1a), which host miR-
nAs. Mouse models employed to study HtR2C function 
still contain the 5′ UtR and the hosted miRnAs (tecott  
et al. 1995; Xu et al. 2008), and it is therefore possible that 
the mouse knockouts capture only the protein function of 
the HtR2C transcriptional unit, but not its function as a host 
of miRnAs.
miRnAs are 22nt long non-coding RnAs. the major-
ity of miRnAs reside in pre-mRnA, both in the UtRs and 
in introns. In the nuclear pre-mRnA, miRnAs are part of 
extended double-strand structures forming pri-miRnAs 
that are recognized and cleaved by DROSHA/DGCR8, 
forming pre-miRnA that are exported into the cytosol. In 
the cytosol, DICER forms mature miRnAs that are loaded 
on argonaute proteins. miRnAs act in gene regulation by 
binding to mRnA, where they can block translation, cause 
RnA decay, RnA cleavage, as well as chromatin silencing 
(Esteller 2011).
Here, we report that the HtR2C gene expresses exons 
1–3 and miRnAs located in intron 2 in non-neuronal 
cell lines, demonstrating that part of the HtR2C gene is 
expressed outside the brain and in non-neuronal cell types. 
the abundance of the encoded miRnAs is regulated by 
MBII-52 and MBII-85, two RnAs implicated in Prader–
Willi syndrome. Since miRnAs encoded by HtR2C intron 
2 are broadly expressed and detectable in lymphocytes, they 
contribute to the gene function in non-neuronal cells and 
could allow to monitor the response of the HtR2C gene to 
drug treatments.


















































Fig. 1  Expression of miRnAs located in serotonin receptor intron 
2 in different cell lines. a Schematic diagram of the serotonin recep-
tor 2C pre-mRnA. b–d qRt-PCR showing amplification of miRnAs. 
the amount of miRnAs in human cortex tissue was set to one, and 
miRnA abundance in other cells was expressed as a fraction of the 
expression in cortex




HEK 293t cells were transiently transfected with plas-
mids coding for MBII-52 and MBII-85 snoRnA (mouse 
orthologous of SnORD115 and SnORD116 respectively). 
total RnA was isolated from cells using trizol LS reagent 
(Invitrogen) according to manufactory protocol.
As a probe, we used a uniformly labeled RnA against 
mouse chr7:59,520,283–59,520,365 for MBII-52 and 
chr7:59,861,729–59,861,827 for MBII-85, as previously 
described (Shen et al. 2011).
RnAs from human cortex was isolated using the Rneasy 
Lipid tissue Kit (Qiagen, Hilden) according to manufactory 
protocol.
Cell culture
the HEK293, HeLa, and A549 cells were obtained from the 
American type Culture Collection (AtCC). RH18 cells were 
obtained from St. Jude Children’s Research Hospital, and the 
primary human fibroblast cells were obtained from Coriell 
Institute (GM 00498D). All the cells were grown in the recom-
mended medium containing 10 % fetal bovine serum (FBS) at 
37 °C under 5 % CO2. Lymphocytes were collected from the 
blood of a healthy male donor and were purified using ACCUS-
PIn System-Histopaque-1077 (nishimura et al. 2007).
Rt-PCR
Sixty nanograms of total RnA (30 ng/μl), 5 pmol of reverse 
primer, and 40 U of SuperScript III reverse transcriptase 
(Invitrogen) were mixed in 5 μl of Rt (reverse transcription) 
buffer. to reverse transcribe the RnA, the reaction was incu-
bated at 55 °C for 50 min. Half of the Rt reaction was used 
for cDnA amplification. the reaction was performed in 25 μl 
and contained 10 pmol of specific forward and reverse prim-
ers, 200 μM dntPs, 1× taq polymerase buffer, and 1 U of 
taq DnA polymerase. the amplification was performed in an 
Eppendorf PCR System with the following conditions: initial 
denaturation for 4 min at 94 °C, optimized number of cycles 
(30 cycles for cDnAs from cortex and for β-actin; 40 cycles 
for 5Ht2C cDnAs from cells) for 30 s at 94 °C, 30 s at 55 °C 
and an extension of 45 s at 72 °C. After the last cycle, the 
reaction was held for 5 min at the extension temperature to 
complete the amplification of all products.
Brain tissues
Cortex tissues were obtained postmortem from three patients 
with Prader–Willi syndrome and three individuals as a con-
trol group. the tissue was obtained from the nICHD brain 
bank in Maryland. A detailed analysis of the tissues was per-
formed in (Falaleeva et al. 2013).
taqMan analysis
thirty nanograms of total RnA, 1× Rt primer, 15 mM 
dntPs, 50 U of SuperScript III Reverse transcriptase, 1× 
Rt (Reverse transcription) buffer, 4 U of Rnase inhibitor 
were mixed in a 15 μl Rt reaction. the reverse transcrip-
tion was performed under the following condition: 30 min at 
16 °C, 30 min at 42 °C, and 5 min at 85 °C.
One-fifth of the Rt reaction was used for the qPCR. the 
reaction was performed in 20 μl and contained 1× taqMan 
MicroRnA assay primer, 1× taqMan universal PCR Master 
Mix no AmpErase UnG (Applied Biosystems). the ampli-
fication was carried out in a Stratagene Mx3000p thermo-
cycler with the following conditions: initial denaturation for 
10 min at 95 °C, 40 cycles for 15 s at 95 °C, and an exten-
sion of 1 min at 60 °C.
RnA isolation and deep sequencing
RnA was extracted from supraspliceosomes prepared from 
frozen HeLa cells (CILBIOtECH), as previously described 
(Azubel et al. 2006). the integrity of the RnA was evaluated 
by an Agilent 2100 bioanalyzer. For small RnA library con-
struction, ~10 mg of RnA was used, following the Illumina 
Directional mRnA-Seq Library Prep. (Pre-release Protocol) 
with the following changes: (1) the poly-A selection and 
fragmentation of mRnA steps were omitted; (2) to enrich 
for small RnAs, ethanol precipitation was used instead of 
column fractionation of the PnK-treated RnA. Adaptors 
were then ligated to the 5′ and 3′ ends of the RnA, and 
cDnA was prepared from the ligated RnA and amplified 
to prepare the sequencing library. the amplified sequences 
were purified by PAGE and sequences representing RnA 
smaller than 200 nt were extracted from the gel. the library 
was sequenced using the Genome AnalyzerIIX System by 
Illumina. the sequencing data, after filtering the adaptors 
and low-quality sequences, were aligned to mirBase.
For RnAse protection assays and miRnA analysis, RnA 
was isolated by trizol LS reagent, and total RnA (including 
small RnAs and ribosomal RnAs) was used.
Search of MBII-85 and MBII-52 targets in the serotonin 
receptor 2C (HtR2C) pre-mRnA
the HtR2C pre-mRnA sequence was downloaded from 
EnSEMBL release 54. Subsequently, for each psnoRnA 
construct from MBII-52 and MBII-85, all the possible sub-
strings with base pairing with any substring of the HtR2C 
genomic sequence were searched exhaustively. the follow-
ing criteria were used as follows: (a) the substrings were 
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at least 15 nucleotides long; (b) Up to 2 mismatches were 
allowed; (c) non-canonical G-U base-pairings were also 
considered.
Results
Detection of miRnAs located in the 5′ UtR by deep 
sequencing
During investigation of the splicing regulation of the sero-
tonin receptor 2C, we performed deep sequencing of non-
coding RnA from supraspliceosomes (Sperling et al. 2008) 
isolated from HeLa cells. the entire repertoire of nuclear 
pre-mRnAs are individually packaged in splicing active 
supraspliceosomes, that likely represent the in vivo compo-
sition of spliceosomes (Sperling et al. 2008). the sequencing 
data showed the expression of miR-764, miR-1260, miR-
1912, and miR-1298. these four miRnAs are located in the 
5′ UtR of the serotonin receptor 2C pre-mRnA, between 
exon 2 and 3 (Fig. 1a). miR-1298 was most abundant with 
4217 reads, followed by miR-1264 with 2560 reads, miR-
764 with 817 reads, and miR-1912 with 522 reads. miR-
764, miR-1264, miR-1912, and miR-1298 are only found in 
the serotonin receptor 2C pre-mRnA. Since the expression 
of the serotonin receptor 2C is considered neuron-specific, 
these results were highly surprising.
Expression of miRnAs in cell lines
We next validated the deep-sequencing findings using 
qRt-PCR employing available taqMan probes for miR-
764, miR-1912, and miR-1264 (there is no probe avail-
able for miR-1298). We tested total RnA from several 
different cell lines: HEK293 cells (fibroblasts), RH18 
cells (rhabdomyosarcoma), A549 (lung cancer, adeno-
carcinoma), HeLa (cervical cancer), primary lympho-
cytes (from male blood), and human cortex. As shown in 
Fig. 1b, d, we could detect miR-764 and miR-1264 in all 
cell lines tested, but miR-1912 only in primary lympho-
cytes. As expected, all miRnAs are expressed in human 
brain (cortex), considered to be the only expressing tis-
sue (Canton et al. 1996). Unexpectedly, miR-1264 is 
expressed at higher ratios in cell lines than in cortex. the 
qPCR analysis is in agreement with the read count of the 
deep-sequencing data and indicated an expression pattern 
of miR-1264 > miR-764 > miR1912.
the 5′ untranslated region of serotonin receptor 2C  
gene is widely expressed
We next determined the expression of the 5′ untranslated 
pre-mRnA region of serotonin receptor 2C (Fig. 2a) that 
hosts the miRnAs in intron 2. Using flanking primers in 
exon two and three, we observed amplification in all cell 
lines tested. In contrast, there was no amplification when we 
used primers in exons four and six (Fig. 2b, c). these data 
indicate that the Ht2CR generates two mRnAs, one cor-
responding to the 5′ UtR (exons 1–4) and one correspond-
ing to the full-length RnA (exons 1–6). the long mRnA 
composed of exons 1–6 has previously been detected in 
northern Blots (Canton et al. 1996) using brain tissue. the 
existence of shorter mRnAs corresponding to the 5′ UtR is 
supported by an expressed sequence tag, DC317996, which 
encompasses exon 1–4. In the absence of an open reading 
frame, the function of the mRnA corresponding to exons 
1–4 is likely to host several miRnAs.
Changes of miRnAs in brains of subjects  
with Prader–Willi syndrome (PWS)
the serotonin receptor 2C undergoes alternative pre-mRnA 
splicing in exon V. the inclusion of exon Vb is promoted 
by processed snoRnAs generated from the MBII-52 cluster 
(Kishore and Stamm 2006b; Falaleeva and Stamm 2013). 
Data from mouse systems indicate that this regulation 
occurs in vivo (Doe et al. 2009). We therefore asked whether 
MBII-52 influences the expression of miRnAs located in 
Ht2CR intron 2.
First, we analyzed tissue samples obtained from patients 
with PWS and compared them to controls. Patients 
with PWS do not express SnORD115/MBII-52 and 
SnORD116/MBII-85. In all cases, similar frontal corti-
cal regions were used. As shown in Fig. 3a, PWS patients 
express less miR-764 and miR-1912 than controls but 
express more miR-1264 than controls.
next, we determined the expression of the exons flank-
ing the hosting intron and found them significantly lower 
expressed than the exons from controls (Fig. 3b).
the data suggest that miRnA expression could be influ-
enced by the lack of SnORD115/116 RnAs in Prader–Willi 
syndrome subjects.
transfection of MBII-52 and MBII-85 changes abundance 
of miRnAs expressed from intron 2
to test the influence of MBII-52 and MBII-85 on miRnA 
abundance directly, we transfected HEK293 cells with 
expression constructs generating MBII-52 and MBII-85. 
the expression of MBII-52 and MBII-85 was measured 
by Rnase protection analysis (Fig. 4a, b). We then meas-
ured the abundance of miR-764, miR-1264, and miR-1912 
by qRt-PCR. As shown in Fig. 4c, miR-764 was strongly 
upregulated by expression of MBII-52 and MBII-85. In 
contrast, miR-1264 was downregulated. miR-1912 could 
not be detected. these changes mirror the situation in 
391Exp Brain Res (2013) 230:387–394 
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PWS subjects, where miR-764 is down and miR-1264 is 
upregulated.
next, we determined the influence of MBII-52 and 
MBII-85 on the expression of the hosting intron using Rt-
PCR that amplifies the flanking exons 2–3. As shown in 
Fig. 4d (quantified in Fig. 4e), we found an upregulation of 
the exons caused by the overexpression of both psnoRnAs.
together, the data suggest an influence of MBII-52 and 
MBII-85 on the expression of miR-764 and miR-1264 and 
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Fig. 2  Expression of hosting 
exons for miRnAs. a Schematic 
illustration of the primers used 
for amplification. b Rt-PCR 
amplification of intron 2 hosting 
the miRnAs. Primers in exon 2 
and 3 indicated in a were used. 
c Rt-PCR amplification of the 
coding region of the Ht2CR 
using primers in exon 4 and 6.  
d Rt-PCR amplification of 





Fig. 3  Changes of miRnAs 
in PWS samples. a qRt-PCR 
results using cortex samples 
from controls and PWS patients. 
b Rt-PCR of intron 2, β-actin 
was used as a loading control. 
c Quantification of data from 
panel b. the means and SD are 
shown
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target sequences of MBII-52 and MBII-85 in the serotonin 
receptor pre-mRnA
We analyzed binding sites for MBII-52 and MBII-85 on the 
serotonin receptor pre-mRnA. Very little is known so far 
about how psnoRnAs bind to their targets. Accordingly, we 
performed an unbiased, exhaustive search of potential tar-
gets of MBII-52 and MBII-85 psnoRnA constructs on the 
serotonin receptor 2C (HtR2C) gene. We initially searched 
for at least 15 nt matches and allowed up to two mismatches 
between psnoRnA sequences and the serotonin receptor 2C 
pre-mRnA. As shown in Fig. 5, we detect binding sites 
for MBII-52 and MBII-85 on the receptor 2C pre-mRnA, 
flanking the pre-miRnA stem-loop structure. All putative 
binding sites are visualized on the UCSC browser, under 
http://regulatorygenomics.upf.edu/Projects/htr2c-targets.html.
As shown in Fig. 5a–d, most of these binding sites are 
in evolutionary conserved regions. Importantly, the bind-
ing sites are conserved between the mouse and human 
copies. However, there are numerous binding sites in the 
intron as well. therefore, the exact mechanism remains to 
be determined.
Discussion
HtR2C gives rise to mRnA widespread expression
Unexpectedly, we found that intron 2 of the serotonin recep-
tor 2C is expressed in all cell lines investigated, which 
is in contrast to the protein-coding region of the HtR2C 





Fig. 4  Influence of MBII-52 and MBII-85 overexpression on miR-
nAs. a Schematic illustration of the Rnase protection assay. the 
RnA:RnA hybrid formed between in vitro transcribed radiola-
beled RnA and target RnA is shown (left). treatment with Rnase 
A/t1 removes single-stranded regions and leaves protected psnoR-
nAs (right). b Expression of MBII-52 and MBII-85 snoRnAs in 
HEK293t cells and mouse brain. HEK293 cells were transfected 
with snoRnAs expression constructs (1 μg plasmid per 1 ml media). 
total RnA was isolated from mouse brain (brain) and HEK293 cells 
(cells) after 42 h of transfection and analyzed by Rnase protection 
assay as described (Shen et al. 2011). Arrows show full-length snoR-
nAs, additional lower bands show snoRnAs processing products. 
c Rt-qPCR amplification of miRnAs encoded in intron 2. total RnA 
was extracted from HEK293 cells transfected with control plasmid-
expressing EGFP-C2, MBII-52 or MBII-85 snoRnAs (n = 4). d Rt-
PCR amplification of the flanking intron 2, and the amplification of 
β-actin mRnA as loading control. e Quantification of Rt-PCR results 
shown on 4D. Exon 2 and 3 expression normalized to the expression 
of β-actin and plotted on a chart
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transcriptional termination signal prior to exon 4 that is 
not used in neurons. In contrast to other cells, neurons will 
therefore express the full-length mRnA encoding the pro-
tein. this notion is supported by ESts encompassing only 
the first three exons and by the observation that HtR2C 
mRnA from brain has the predicted size of one long mRnA 
containing exons one to six. Furthermore, databases indi-
cate the presence of CpG islands only in exon I, suggesting 
that there is only one transcriptional start site. the HtR2C 
transcriptional unit is therefore more complex than previ-
ously thought.
the expression of HtR2C intron 2 could have practical 
use, as it offers the possibility to monitor HtR2C expres-
sion under various pharmacological treatments that target the 
encoded protein. numerous gene systems show a regulation 
between the 3′ UtR or encoded proteins and gene expres-
sion. Given the pharmacological importance of HtR2C, it 
will be interesting to investigate whether the miRnAs change 
during treatment with drugs that target HtR2C protein.
miRnAs encoded by HtR2C have different regulation
the 5′ UtR of the HtR2C gene functions to host the miR-
nAs. Whereas intron 2 expression is comparable between 
cell lines, the miRnAs show differences in expression, 
which suggest a further regulation, either a cell-type- 
specific processing of the pre-miRnA or a cell-type-specific 
stability.
the function of these miRnAs and their regulation 
remains to be determined. Mir-764-5p promotes osteoblast 
differentiation as it translationally represses Hsc70-interact-
ing protein/StIP1 homology and U-Box containing protein 
1 (CHIP/StUB1), which promotes osteoblast differentia-
tion (Guo et al. 2012). Although there are no experimentally 
validated targets for the other miRnAs, it is almost cer-
tain that they control other cellular processes, which adds 
to the function of the serotonin receptor 2C pre-mRnA. 
these functions were not captured by knock-out mice that 





Fig. 5  Bioinformatically predicted binding sites of MBII-52 and 
MBII-52 located next to miRnAs in intron 2. the top line shows a 
schematic representation of intron 2. Numbers indicate the coordi-
nates in human genome built (Hg19). psnoRnA-binding sites are 
indicated by small boxes; square: MBII-85, oval: MBII-52. a–d 
Alignment and phylogenetic conservation of the binding sites. the 
human sequences closest to the mouse sequences are indicated with 
their copy numbers in Hg19 after SnORD115 and SnORD116 
(shown in red) (color figure online)
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encoding intron 2 intact (tecott et al. 1995; Xu et al. 2008). 
the knock-out mice were mostly studied with regard to 
changes in food intake, and it will be interesting to analyze 
whether the intron 2-encoded miRnAs can modify the phe-
notype or are deregulated in these knock-out mice.
psnoRnAs from the MBII-52 and MBII-85 loci influence 
the expression of encoded miRnAs
Inclusion of the serotonin receptor’s alternative exon Vb is 
promoted by processed snoRnAs from the MBII-52 cluster 
(Kishore and Stamm 2006b; Kishore et al. 2010). We there-
fore tested whether the two psnoRnAs, MBII-52 and MBII-
85, influence expression of miRnAs encoded in intron 2. 
transfection studies showed that both psnoRnAs increase 
abundance of the exons flanking intron 2, suggesting an 
influence on the pre-mRnA. this finding is supported by 
the analysis of postmortem material, where we found less 
exon change to two/three expression in samples from PWS 
patients who do not express these psnoRnAs.
the effect of psnoRnAs on the encoded miRnAs is more 
complicated, as miR764 is promoted by MBII-52 and MBII-
85, whereas miR1264 is repressed. this interdependency is 
reflected in samples from PWS subjects, but the mechanism 
for the different regulations is not clear. We also noticed that 
one patient (4805) expressed less mir-1264 than controls, 
which is different from the other PWS subjects tested. the 
reason for this difference is not clear.
nonetheless, our data show that a deregulation of micro-
RnAs located in intron 2 of the serotonin receptor 2C likely 
contribute to the Prader–Willi syndrome phenotype.
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